BG104061A - Method for fat absorption reduction by an antilipase antibody - Google Patents

Method for fat absorption reduction by an antilipase antibody

Info

Publication number
BG104061A
BG104061A BG104061A BG10406100A BG104061A BG 104061 A BG104061 A BG 104061A BG 104061 A BG104061 A BG 104061A BG 10406100 A BG10406100 A BG 10406100A BG 104061 A BG104061 A BG 104061A
Authority
BG
Bulgaria
Prior art keywords
antilipase
antibody
fat absorption
absorption reduction
lipase
Prior art date
Application number
BG104061A
Other languages
Bulgarian (bg)
English (en)
Inventor
Julio Pimentel
Original Assignee
Ximed Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ximed Group Plc filed Critical Ximed Group Plc
Publication of BG104061A publication Critical patent/BG104061A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
BG104061A 1997-07-07 2000-01-06 Method for fat absorption reduction by an antilipase antibody BG104061A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/888,202 US7344713B1 (en) 1997-07-07 1997-07-07 Decreased fat absorption with an anti-lipase antibody
PCT/GB1998/001998 WO1999002187A2 (fr) 1997-07-07 1998-07-06 Reduction de l'absorption des graisses au moyen d'un anticorps inhibant la lipase

Publications (1)

Publication Number Publication Date
BG104061A true BG104061A (en) 2000-11-30

Family

ID=25392734

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104061A BG104061A (en) 1997-07-07 2000-01-06 Method for fat absorption reduction by an antilipase antibody

Country Status (14)

Country Link
US (1) US7344713B1 (fr)
EP (1) EP1001809B1 (fr)
JP (1) JP2001525314A (fr)
CN (1) CN1269728A (fr)
AT (1) ATE260115T1 (fr)
AU (1) AU8232698A (fr)
BG (1) BG104061A (fr)
BR (1) BR9815504A (fr)
CA (1) CA2295735A1 (fr)
DE (1) DE69821946D1 (fr)
HU (1) HUP0002753A2 (fr)
IL (1) IL133881A0 (fr)
TR (1) TR200000002T2 (fr)
WO (1) WO1999002187A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618624B1 (en) * 1999-01-07 2009-11-17 Anitox Corporation Weight control using an anti-lipase antibody
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
GB2389362B (en) * 2002-06-05 2006-02-15 Walcom Animal Science Antibodies to adipose tissues
CA2521997A1 (fr) * 2003-04-10 2004-10-21 Ghen Corporation Agent anti-obesite dans lequel sont utilises des anticorps d'oeufs de poule contre les enzymes digestives
WO2008013455A1 (fr) * 2006-07-27 2008-01-31 Lactive B.V. Moyens et procédés de prévention de taux de glycémie élevés chez les humains avec des anticorps animaux produits dans le lait
US10053516B2 (en) * 2013-12-02 2018-08-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
US10538593B2 (en) 2013-12-02 2020-01-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
JP6872841B2 (ja) * 2014-04-28 2021-05-19 アサマ化成株式会社 脂肪低減組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (fr) * 1983-06-22 1988-12-28 Paul Hadvary Derives de leucine
CA1306946C (fr) * 1985-11-25 1992-09-01 Hideo Tokoro Anticorps specifique contenant une substance provenant des oeufs, et methode de production et d'utilisation de cet anticorps
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPH0745520B2 (ja) * 1988-08-31 1995-05-17 国際試薬株式会社 モノクローナル抗体およびその使用法
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants

Also Published As

Publication number Publication date
WO1999002187A2 (fr) 1999-01-21
JP2001525314A (ja) 2001-12-11
ATE260115T1 (de) 2004-03-15
EP1001809B1 (fr) 2004-02-25
BR9815504A (pt) 2000-11-28
DE69821946D1 (de) 2004-04-01
IL133881A0 (en) 2001-04-30
WO1999002187A3 (fr) 2001-06-07
CA2295735A1 (fr) 1999-01-21
US7344713B1 (en) 2008-03-18
TR200000002T2 (tr) 2000-09-21
EP1001809A1 (fr) 2000-05-24
AU8232698A (en) 1999-02-08
CN1269728A (zh) 2000-10-11
HUP0002753A2 (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
EP1142485A3 (fr) Procede destiné a ameliorer la solubilité de proteines vegetales
EP0854917A4 (fr) Animaux non humains transgeniques pouvant produire des anticorps heterologues
EP0942959A4 (fr) Animaux transgeniques non humains capables de produire des anticorps heterologues
ES2169219T3 (es) Aditivos alimenticios para animales que comprenden xilanasa.
MY125875A (en) Method and food product for increasing muscle protein and reducing fat in animals
NZ331299A (en) Antibody variants with reduced affinity for a cell-surface antigen
DE60126104D1 (de) Ernährungszusammensetzung und verfahren zur verbesserung der absetzung von proteinen
NO2009012I1 (no) Humanisert anti-humant IL-6 reseptor monoklonalt antistoff
IL97653A0 (en) Catalytic antibody components
ATE457175T1 (de) Verfahren und zusammensetzung zur verbesserung des wachstums von fleischgeflügel
ES8305564A1 (es) Un metodo de preparar un producto de proteina de leche artificial .
NZ191757A (en) Manufacture of cheese by adding starter culture to pre-mix of protein and fat concentrates and cultured component of proteolysed milk protein and lipolysed fat
BG104061A (en) Method for fat absorption reduction by an antilipase antibody
DK0444891T3 (da) Fødevarebestanddel med den funktion at forbedre serumlipid
CA2122863A1 (fr) Briquette de supplement alimentaire pour animaux
ATE412754T1 (de) Mikrobiell erzeugtes rennin mit verbesserter milchgerinnungsaktivität und verfahren zu dessen herstellung
WO1998018003A3 (fr) Procede permettant d'etablir l'origine d'animaux utiles et produits qui en sont issus
WO2001084949A3 (fr) Sources de proteines et de lipides utilisees dans l'alimentation de la faune aquatique et dans l'alimentation animale et procede de preparation
WO1999024835A3 (fr) Immuno-essai pour propeptide de procollagene iii a terminal c
FI881122A (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
WO2003011220A3 (fr) Modele animal pour comportements neurologiques associes a l'amide d'acide gras
HK1048323B (zh) 家畜乳房分泌抗體的製作
GR1002419B (el) Μεθοδος επεξεργασιας φυτικων προιοντων με βαση την ελατη για παραγωγη εκχυλισματος με βιολογικες δρασεις και χρηση του για τη θεραπεια νοσων στον ανθρωπο και στα ζωα.
FR2361072A1 (fr) Ingredient d'aliment pour animaux
DK0766923T3 (da) Vildfuglefoder